MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
4.240
+0.050 (1.19%)
At close: Nov 10, 2026, 4:00 PM EST
4.210
-0.030 (-0.71%)
After-hours: Nov 10, 2026, 5:55 PM EST

MannKind Revenue

MannKind had revenue of $101.87M in the quarter ending September 30, 2026, with 24.04% growth. This brings the company's total for the last twelve months to $413.37M, up 31.74% year-over-year. In the year 2025, MannKind had annual revenue of $348.97M with 22.23% growth. That makes MannKind the 12,394th largest company in the world by revenue and 2,409th in the United States.

Revenue (ttm)
$413.37M
Revenue Growth
+31.74%
P/S Ratio
3.28
Revenue / Employee
$698,262
Employees
592
Market Cap
1.36B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025348.97M63.46M22.23%
Dec 31, 2024285.50M86.54M43.50%
Dec 31, 2023198.96M99.19M99.42%
Dec 31, 202299.77M24.33M32.25%
Dec 31, 202175.44M10.30M15.81%
Dec 31, 202065.14M2.11M3.34%
Dec 31, 201963.04M35.18M126.28%
Dec 31, 201827.86M16.11M137.20%
Dec 31, 201711.75M-163.01M-93.28%
Dec 31, 2016174.76M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
UroGen Pharma250.25M
Nektar Therapeutics54.59M
Omeros38.42M
Inhibrx Biosciences1.30M
Silence Therapeutics615.00K
Revenue Rankings